Lord Abbett Health Care C (LHCCX)

Fund Assets	8.74M
Expense Ratio	1.726%
Min. Investment	$1,500
Turnover	91.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	22.51
YTD Return	3.12%
1-Year Return	12.61%
5-Year Return	17.56%
52-Week Low	19.49
52-Week High	23.76
Beta (5Y)	n/a
Holdings	55
Inception Date	Jul 31, 2019

About LHCCX

Lord Abbett Health Care Fund Class C is an actively managed mutual fund that focuses on delivering long-term capital growth by investing primarily in equities of companies within the health care sector. The fund targets a diverse array of health care industries, including pharmaceuticals, biotechnology, medical devices, and health care services, providing investors with comprehensive exposure to one of the most dynamic areas of the global economy. Since its inception in 2019, the fund has sought to capitalize on innovation and demographic trends that drive demand for health solutions. Its investment approach emphasizes identifying companies poised for growth due to advancements in science, technology, and changing health care needs. The fund plays a significant role for investors seeking sector-specific diversification, particularly those interested in benefitting from structural shifts in health care, such as aging populations and evolving medical technologies. Lord Abbett Health Care Fund Class C is structured to accommodate retail investors, offering professional management and reinvestment of distributions, while its expense structure reflects the costs associated with active sector investing.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: LHCCX
• Share Class: Class C
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCCX had a total return of 12.61% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.49%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%

Top 10 Holdings

44.28% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	5.57%
Johnson & Johnson	JNJ	5.11%
Novartis AG	NOVN	4.32%
Natera, Inc.	NTRA	3.71%
Gilead Sciences, Inc.	GILD	3.64%
CVS Health Corporation	CVS	3.44%
Guardant Health, Inc.	GH	2.69%
Galderma Group AG	GALD	2.68%
Thermo Fisher Scientific Inc.	TMO	2.39%

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 17, 2026

Data Sources Report a data error